CEL-SCI Corp - Company Profile

Powered by

All the data and insights you need on CEL-SCI Corp in one report.

$195 $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date CEL-SCI Corp Strategy Report

  • Understand CEL-SCI Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

CEL-SCI Corp: Overview

Select Item

CEL-SCI Corp (CEL-SCI) is a biotechnology company that carries out the research and development of new immunotherapy products for the treatment of various cancer, autoimmune, and infectious diseases. Its core capabilities include drug discovery, research, development and manufacture of compound biological substances. CEL-SCI’s lead candidate Multikine (leukocyte interleukin), is an investigational immunotherapy against cancer and human papilloma virus (HPV). The company is also investigating an immunotherapy (LEAPS-H1N1-DC) as a possible treatment for H1N1 in hospitalized patients and vaccines, CEL-2000 and CEL-4000 for rheumatoid arthritis using Ligand Epitope Antigen Presentation System (LEAPS) technology platform. CEL-SCI is headquartered in Fairfax, Virginia, the US.

 Gain a 360-degree view of CEL-SCI Corp and make more informed decisions for your business Gain a 360-degree view of CEL-SCI Corp and make more informed decisions for your business Find out more
Headquarters United States of America
Address Suite 802, 8229 Boone Blvd ., Vienna, Virginia, 22182
Website cel-sci.com
Telephone 1 703 5069460
No of Employees 43
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange CVM (AFM)
EPS XYZ
Net Income (2022) XYZ 12.3% (2022 vs 2021)
Market Cap* $82.1M
Net Profit Margin (2019) XYZ 0.0% (2022 vs 2021)
   
* As of and is in US$
View CEL-SCI Corp financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

CEL-SCI Corp premium industry data and analytics

15+

Clinical Trials

Determine CEL-SCI Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

7

Pipeline Drugs

Identify which of CEL-SCI Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

5

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for CEL-SCI Corp’s relevant decision makers and contact details.

4

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

4

Catalyst Calendar

Proactively evaluate CEL-SCI Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products Brands
Pipeline - -
Multikine: Multikine
Head and Neck Cancer
XYZ
XYZ
XYZ
Understand CEL-SCI Corp portfolio and identify potential areas for collaboration Understand CEL-SCI Corp portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters CEL-SCI Corp ImmunoGen Inc Bioqual Inc Chinook Therapeutics Inc Biopolymer Innovations Llc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Vienna Waltham Rockville Seattle East Lansing
State/Province Virginia Massachusetts Maryland Washington Michigan
No. of Employees 43 277 108 214 5
Entity Type Public Private Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Geert R. Kersten Treasurer; Chief Executive Officer; Director Executive Board 1995 62
Eyal Talor, Ph.D. Chief Scientific Officer Senior Management 2009 66
Patricia B. Prichep Senior Vice President - Operations; Secretary Senior Management 1994 71
William Jones Vice President - Quality Assurance Senior Management 1999 -
John Cipriano Senior Vice President - Regulatory Affairs Senior Management 2009 80
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into CEL-SCI Corp key executives to enhance your sales strategy Gain insight into CEL-SCI Corp key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward